Patients Growing health inequality in UK prompts call for ‘joined up ... In the last UK election in 2019, the NHS emerged as a major talking point, as the scale of the country’s support of the service was brought to the fore.
Market Access Big pharma is slimming down The last few years have been marked by many big pharma companies opting to move away from diversification and towards more focused operations.
News UK biotech sees worst funding downturn since 2012 The UK BioIndustry Association (BIA) and data and insights company Clarivate have released their annual UK Biotech Financing report
R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face